These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30582376)

  • 21. The role of the 5' terminal region of p53 mRNA in the p53 gene expression.
    Swiatkowska A; Zydowicz P; Sroka J; Ciesiołka J
    Acta Biochim Pol; 2016; 63(4):645-651. PubMed ID: 27776193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence.
    Fujita K; Mondal AM; Horikawa I; Nguyen GH; Kumamoto K; Sohn JJ; Bowman ED; Mathe EA; Schetter AJ; Pine SR; Ji H; Vojtesek B; Bourdon JC; Lane DP; Harris CC
    Nat Cell Biol; 2009 Sep; 11(9):1135-42. PubMed ID: 19701195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinctive patterns of p53 protein expression and microsatellite instability in human colorectal cancer.
    Nyiraneza C; Jouret-Mourin A; Kartheuser A; Camby P; Plomteux O; Detry R; Dahan K; Sempoux C
    Hum Pathol; 2011 Dec; 42(12):1897-910. PubMed ID: 21665242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Emerging Landscape of p53 Isoforms in Physiology, Cancer and Degenerative Diseases.
    Anbarasan T; Bourdon JC
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Diverse Functions of Mutant 53, Its Family Members and Isoforms in Cancer.
    Hall C; Muller PAJ
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer-specific mutations in p53 induce the translation of Δ160p53 promoting tumorigenesis.
    Candeias MM; Hagiwara M; Matsuda M
    EMBO Rep; 2016 Nov; 17(11):1542-1551. PubMed ID: 27702985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of p53 isoforms in renal cell carcinoma.
    Song W; Huo SW; Lü JJ; Liu Z; Fang XL; Jin XB; Yuan MZ
    Chin Med J (Engl); 2009 Apr; 122(8):921-6. PubMed ID: 19493415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Influence of Quadruplex Structure in Proximity to P53 Target Sequences on the Transactivation Potential of P53 Alpha Isoforms.
    Porubiaková O; Bohálová N; Inga A; Vadovičová N; Coufal J; Fojta M; Brázda V
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of p73 in malignancy: tumor suppressor or oncogene?
    Stiewe T; Pützer BM
    Cell Death Differ; 2002 Mar; 9(3):237-45. PubMed ID: 11859406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers.
    Bischof K; Knappskog S; Hjelle SM; Stefansson I; Woie K; Salvesen HB; Gjertsen BT; Bjorge L
    Sci Rep; 2019 Mar; 9(1):5244. PubMed ID: 30918304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53: more research and more questions.
    Braithwaite AW; Prives CL
    Cell Death Differ; 2006 Jun; 13(6):877-80. PubMed ID: 16708075
    [No Abstract]   [Full Text] [Related]  

  • 32. Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer.
    Steffens Reinhardt L; Groen K; Morten BC; Bourdon JC; Avery-Kiejda KA
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743117
    [No Abstract]   [Full Text] [Related]  

  • 33. The continuing saga of p53--more sleepless nights ahead.
    Prives C; Manfredi JJ
    Mol Cell; 2005 Sep; 19(6):719-21. PubMed ID: 16168367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression.
    Bernard H; Garmy-Susini B; Ainaoui N; Van Den Berghe L; Peurichard A; Javerzat S; Bikfalvi A; Lane DP; Bourdon JC; Prats AC
    Oncogene; 2013 Apr; 32(17):2150-60. PubMed ID: 22733133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 isoforms can regulate p53 transcriptional activity.
    Bourdon JC; Fernandes K; Murray-Zmijewski F; Liu G; Diot A; Xirodimas DP; Saville MK; Lane DP
    Genes Dev; 2005 Sep; 19(18):2122-37. PubMed ID: 16131611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in p53 research and cancer treatment.
    Suzuki K; Matsubara H
    J Biomed Biotechnol; 2011; 2011():978312. PubMed ID: 21765642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IRES mediated translational regulation of p53 isoforms.
    Sharathchandra A; Katoch A; Das S
    Wiley Interdiscip Rev RNA; 2014; 5(1):131-9. PubMed ID: 24343861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TP53 is not a prognostic marker-clinical consequences of a generally disregarded fact.
    Braunschmid T; Kührer I; Mittlböck M; Westerhoff M; Kappel-Latif S; Brammen L; Krishnadath KK; Phillips WA; Gnant M; Kandioler D
    Ann N Y Acad Sci; 2018 Dec; 1434(1):46-53. PubMed ID: 30112858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation analysis of p53 protein isoforms with NPM1/FLT3 mutations and therapy response in acute myeloid leukemia.
    Ånensen N; Hjelle SM; Van Belle W; Haaland I; Silden E; Bourdon JC; Hovland R; Taskén K; Knappskog S; Lønning PE; Bruserud Ø; Gjertsen BT
    Oncogene; 2012 Mar; 31(12):1533-45. PubMed ID: 21860418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 downstream target genes and tumor suppression: a classical view in evolution.
    Rozan LM; El-Deiry WS
    Cell Death Differ; 2007 Jan; 14(1):3-9. PubMed ID: 17068503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.